KramerR.M., HessionC., JohansenB.Structure and properties of a human non-pancreatic phospholipase A2.J Biol Chem1989; 264: 5768–75.
2.
PruzanskiW., VadasP.Soluble phospholipase A2 in human pathology: clinical- laboratory interface.Adv Exp Med Biol1990; 275: 83–101.
3.
PeuravuoriH.J., FunatomiH., NevalainenT.J.Group I and group II phospholipases A2 in serum in uraemia.Eur J Clin Chem Clin Biochem1993; 31: 491–4.
4.
MortonA.R., VadasP., StefanskiE., PruzanskiW., PierratosA.Increased levels of phospholipase A2 in renal failure patients. The American Society of Nephrology Meeting 1989.
5.
BaurM., SchmidT.O., LandauerB.Role of phospholipase A in multiorgan failure with special reference to ARDS and acute renal failure (ARF).Klin Wochenschr1989; 67: 196–202.
6.
SmithG.M., WardR.L., McGuiganL., RajkovicI.A., ScottK.F.Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA.Br J Rheumatol1992; 31: 175–8.
CostelloJ., FransonR.C., LandwehrK., LandwehrD.M.Activity of phospholipase A2 in plasma increases in uraemia.Clin Chem1990; 36: 198–200.
9.
PruzanskiW., KeystoneE.C., Stern byB., BombardierC., SnowK.M., VadasP.Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis.J Rheumatol1988; 15: 1351–5.
10.
VadasP., PruzanskiW., StefanskiE.Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?Agents Actions1988; 24: 320–5.
11.
BreborowiczA., SombolosK., RodelaH., OgilivieR., BargmanJ., OreopoulosD.Mechanism of phosphatidylcholine action during peritoneal dialysis.Perit Dial Bull1987; 7: 6–9.
12.
Di PauloN., BuoncristianiU., GaggiottiE., CapotondoL., De MiaM.Improvement of impaired ultrafiltration after addition of phosphatidylcholine in patients on CAPD.Perit Dial Int1989; 9: 211–13.